A study at the Swedish medical university Karolinska Institutet has revealed that the so-called bad cholesterol (LDL) inhibits the breakdown of fat in cells of peripheral deposits.
The new finding reveals a novel function of LDL as a regulator of fat turnover, besides its well-established detrimental effects in promoting atherosclerosis.
High Density Lipoproteins
HDL is a type of Lipoprotein. Lipoproteins, as the name suggests, are a class of biochemical compounds formed by a protein component and a lipid component.
Advertisement
During the study, the researchers found that LDL cholesterol slows the rate of fat breakdown (i.e. lipolysis) in adipocytes, the peripheral cells responsible for fat storage.
Previous studies have shown the fatty acids released from the peripheral fat to the blood boost the synthesis of LDL precursors in the liver.
"The results of our study provide evidence of a reciprocal link between the liver and peripheral fat regulating fat turnover", said study-initiator Dr Johan Bjorkegren.
![Heart Attack]( "Heart Attack")
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
The finding also opens up for new theories for the well-established association between blood lipids and the metabolic syndrome.
"If proven of general physiological importance, therapies lowering LDL, as for instances Statins, may also affect the turnover of peripheral fat," Bjorkegren said.
The study was conducted on cell cultures and tissues from humans as well as mouse models with different levels of LDL.
The inhibitory effect was also shown to be dependent on LDL receptors on the surface of the fat cells.
Project leader Dr Josefin Skogsberg said: "The exact intracellular mechanism for how the binding of LDL to the surface of the fat cells inhibits the breakdown of intracellular fat remains to be revealed."
The study is published in the open-access journal PLoS ONE.
Source: ANI
SRM
"The results of our study provide evidence of a reciprocal link between the liver and peripheral fat regulating fat turnover", said study-initiator Dr Johan Bjorkegren.
Heart Attack
Heart attack is the death of the heart muscle due to loss of blood supply. Heart disease is the leading cause of death in the United States. Other names for heart attack include acute myocardial infarction, coronary thrombosis, and coronary occlusion.
Advertisement
The finding also opens up for new theories for the well-established association between blood lipids and the metabolic syndrome.
"If proven of general physiological importance, therapies lowering LDL, as for instances Statins, may also affect the turnover of peripheral fat," Bjorkegren said.
The study was conducted on cell cultures and tissues from humans as well as mouse models with different levels of LDL.
The inhibitory effect was also shown to be dependent on LDL receptors on the surface of the fat cells.
Project leader Dr Josefin Skogsberg said: "The exact intracellular mechanism for how the binding of LDL to the surface of the fat cells inhibits the breakdown of intracellular fat remains to be revealed."
The study is published in the open-access journal PLoS ONE.
Source: ANI
SRM
Animation on Coronary Artery Bypass Surgery (CABG) - Animation
Coronary Artery Bypass Surgery (CABG) is performed to restore the blood supply to areas of heart that have been reduced or has no blood supply due to blockage in the artery.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cholesterol News
Muvalaplin, an oral drug, offers the path-breaking world's first treatment for lipoprotein(a), a bad cholesterol that increases the risk of heart attack and stroke.
Low-density lipoprotein cholesterol (LDL cholesterol) plays a significant role in elevating the likelihood of heart attacks and strokes.
New technology for identifying cholesterol levels that is cheaper, more efficient, and faster than traditional analogues developed.
New research questions the efficacy of statins prescribed to lower cholesterol levels in patients with heart disease.
Lipid profiling may provide the basis for recommending diet and lifestyle interventions before disease development of diabetes and cardiovascular disease.
